Psychomotor Agitation Clinical Trial
Official title:
Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
Scheduled, low-dose quetiapine is effective in preventing delirium in high-risk critically ill, trauma/surgical patients. Prophylaxis also reduced ventilator duration and ICU length of stay.
Objective: To evaluate the efficacy of scheduled quetiapine for delirium prophylaxis in
critically ill, trauma/surgical patients identified as high-risk for delirium utilizing a
validated prediction model.
Design: Prospective, open-label, single-center study. Setting: Trauma/surgical intensive
care unit at an academic medical center. Patients: Eighty two adult trauma/surgical patients
who were admitted to the intensive care unit and were at high-risk for the development of
delirium (PRE-DELIRIC Score ≥50%, past medical history of dementia, past medical history of
alcohol misuse, or past medical history of drug abuse).
Interventions: Patients were randomized by unit location to receive pharmacologic
prophylaxis for delirium (quetiapine 12.5 mg every 12 hours) or no pharmacologic prophylaxis
for delirium within forty-eight hours of admission to the intensive care unit.
Measurements: The primary end point was the incidence of delirium during admission to the
intensive care unit (ICU). Secondary end points included time to onset of delirium, ICU and
hospital lengths of stay, ICU and hospital mortality, duration of mechanical ventilation,
and adverse events. Delirium was assessed using the confusion assessment method for the
intensive care unit.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00723580 -
Actigraphic Analysis of Treatment Response
|
N/A | |
| Completed |
NCT01050478 -
IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation
|
Phase 4 | |
| Completed |
NCT00001770 -
Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)
|
N/A | |
| Completed |
NCT01362959 -
Nicotine Replacement Therapy in the Intensive Care Unit
|
Phase 4 | |
| Completed |
NCT02361476 -
Does Intraoperative Clonidine Reduce Post Operative Agitation in Children?
|
Phase 4 | |
| Completed |
NCT02256358 -
Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation
|
N/A | |
| Recruiting |
NCT01578161 -
The Effect of Dexmedetomidine on Emergence Agitation in Children Undergoing a Surgery Under Desflurane Anesthesia
|
Phase 4 | |
| Completed |
NCT00161473 -
Alzheimer's in Long-Term Care--Treatment for Agitation
|
N/A | |
| Recruiting |
NCT02617056 -
Objective Assessment of Behavioral Associations of Patients With Dementia
|
||
| Completed |
NCT03216941 -
Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward
|
Phase 4 | |
| Completed |
NCT02383004 -
Acupuncture for the Prevention of Emergence Delirium in Children Undergoing Myringotomy Tube Placement
|
N/A | |
| Completed |
NCT01485692 -
Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation
|
N/A | |
| Completed |
NCT00260624 -
Escitalopram Treatment of Patients With Agitated Dementia
|
Phase 4 | |
| Completed |
NCT02027844 -
Cartoon Distraction and Parental Presence on Anxiety in Pediatric Anesthesia
|
N/A | |
| Completed |
NCT01750541 -
Haloperidol vs. Valproate in Agitation
|
Phase 3 | |
| Recruiting |
NCT00122759 -
Ketamine Sedation in Mechanically Ventilated Patients
|
N/A | |
| Completed |
NCT00122733 -
Loxapine and Weaning From Ventilator
|
N/A | |
| Not yet recruiting |
NCT04959279 -
ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care
|
N/A | |
| Not yet recruiting |
NCT04148963 -
A Study of Staccato Loxapine (ADASUVE®) for Inhalation
|
Phase 3 |